A Randomized Open Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Alone vs No Therapy in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3 Who Do Not Wish to Receive Treatment With Antiretroviral Therapy.

Trial Profile

A Randomized Open Label Phase II Study of Subcutaneous Interleukin-2 (Proleukin) Alone vs No Therapy in Patients With HIV Infection and at Least 350 CD4+ Cells/mm3 Who Do Not Wish to Receive Treatment With Antiretroviral Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Aug 2009

At a glance

  • Drugs Aldesleukin (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Oct 2008 Actual end date (Jun 2004) added as reported by CT.gov
    • 28 Sep 2008 Actual initiation date (Jul 1998) added as reported by CT.gov
    • 28 Sep 2008 Status changed from active, no longer recruiting to completed as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top